35453-19-1Relevant articles and documents
Method for preparing 5 -amino -2, 4 and 6 -iodoisophthalate
-
Paragraph 0038-0051, (2021/09/29)
The invention relates to a method for preparing 5 - amino -2, 4 and 6 - triiodoisophthalic acid, in particular to an iodine simple substance. The iodate is reacted with 5 - aminoisophthalic acid or a salt thereof in a mixed solution. The reaction product can be used in the synthesis X-ray imaging diagnosis technology intermediate of contrast medium. The preparation method is convenient and simple in process operation, excellent in yield, safe, environment-friendly and green, and can be used for large-scale industrial production.
Iopamidol synthesis and preparation of iopamidol synthesis intermediate
-
Paragraph 0043; 0044, (2019/02/13)
The invention relates to the technical field of chemical synthesis processes, particularly to iopamidol synthesis and preparation of an iopamidol synthesis intermediate. According to the present invention, by adjusting the feeding weight ratio, optimizing the reaction conditions and improving the iopamidol synthesis route, the requirements on the compound reaction conditions are low, the control of the reaction is simple, and the yield is increased while the quality of the intermediate product is greatly improved so as to reduce the process control difficulty in the iopamidol production process and improve the quality and the qualification rate of iopamidol; and various steps of the preparation process are simple, the solvents and the process conditions are safe and easy to perform, the environmental protection production is achieved, and the method has broad application prospects.
Synthesis and evaluation of potential CT (computer tomography) contrast agents for bone structure and microdamage analysis
Parkesh, Raman,Gowin, Wolfgang,Lee, T. Clive,Gunnlaugsson, Thorfinnur
, p. 3611 - 3617 (2008/09/19)
The design and synthesis of several novel X-ray contrast agents 1-3, developed for targeting bone structures, and in particularly microcracks in bones, using CT (Computer Tomography) detection is described. These contrast agents are based on the use of the well known triiodobenzene platform, which was conjugated into one or more phenyliminodiacetate moieties, which can be used to 'lock' onto bone matrices. Compounds 1-3 were all tested for their ability to visualise cracks in bone structures (bovine bones) using μ-CT imaging. The Royal Society of Chemistry 2006.